These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 1919528

  • 1. Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study.
    Hoshikawa N, Kojima A, Yasuda A, Takayashiki E, Masuko S, Chiba J, Sata T, Kurata T.
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2509-17. PubMed ID: 1919528
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
    Karacostas V, Wolffe EJ, Nagashima K, Gonda MA, Moss B.
    Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
    [Abstract] [Full Text] [Related]

  • 3. Retrovirus-like particles produced by vaccinia viruses expressing gag-pro-pol region genes of bovine leukaemia virus.
    Hertig C, Pye AD, Hyatt AD, Boyle DB.
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2213-21. PubMed ID: 8077921
    [Abstract] [Full Text] [Related]

  • 4. Cell line-dependent release of HIV-like gag particles after infection of mammalian cells with recombinant vaccinia viruses.
    Dru A, Ludosky MA, Cartaud J, Beaud G.
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):383-90. PubMed ID: 7520722
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D, Bolesta E, Naito T, Gzyl J, Kaneko Y, Kozbor D.
    J Hum Virol; 2001 Apr; 4(6):306-16. PubMed ID: 12082397
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Interaction of gag polyprotein-precursors p55 and p48 with p160gag-pol during formation of virus-like particles of HIV-1 with recombinant strains of vaccinia virus].
    Iordanskiĭ SN, Lideman LF, Chikova AK, Gibadulin RA.
    Vopr Virusol; 1997 Apr; 42(5):205-8. PubMed ID: 9424843
    [Abstract] [Full Text] [Related]

  • 12. Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.
    Wu X, Conway JA, Kim J, Kappes JC.
    J Virol; 1994 Oct; 68(10):6161-9. PubMed ID: 8083957
    [Abstract] [Full Text] [Related]

  • 13. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.
    Wagner R, Fliessbach H, Wanner G, Motz M, Niedrig M, Deby G, von Brunn A, Wolf H.
    Arch Virol; 1992 Oct; 127(1-4):117-37. PubMed ID: 1456888
    [Abstract] [Full Text] [Related]

  • 14. [Expression of human immunodeficiency virus gag antigens and formation of virus-like particles in a cell culture, infected with recombinant vaccinia virus strains (an electron-microscopic study)].
    Grigor'ev VB, Lideman LF, Gibadulin RA, Sazykin AIu, Klimenko SM.
    Vopr Virusol; 1995 Oct; 40(6):247-51. PubMed ID: 8686258
    [Abstract] [Full Text] [Related]

  • 15. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.
    Karacostas V, Nagashima K, Gonda MA, Moss B.
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8964-7. PubMed ID: 2479031
    [Abstract] [Full Text] [Related]

  • 16. Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus.
    Hu SL, Travis BM, Garrigues J, Zarling JM, Sridhar P, Dykers T, Eichberg JW, Alpers C.
    Virology; 1990 Nov; 179(1):321-9. PubMed ID: 2219727
    [Abstract] [Full Text] [Related]

  • 17. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J, Morrow CD.
    Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
    [Abstract] [Full Text] [Related]

  • 18. [Formation of virus-like particles by HIV-1 Gag proteins, expressed by a recombinant vaccinia virus].
    Vzorov AN, Tentsov IuIu, Grigor'ev VB, Shulenin SA, Garaev MM, Bogdan OP, Bukrinskaia AG.
    Mol Biol (Mosk); 1990 Jun; 24(6):1666-74. PubMed ID: 2094814
    [Abstract] [Full Text] [Related]

  • 19. Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV.
    Shioda T, Shibuta H.
    Virology; 1990 Mar; 175(1):139-48. PubMed ID: 1689917
    [Abstract] [Full Text] [Related]

  • 20. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
    Gendron K, Dulude D, Lemay G, Ferbeyre G, Brakier-Gingras L.
    Virology; 2005 Apr 10; 334(2):342-52. PubMed ID: 15780884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.